ArticleBMC musculoskeletal disorders2025
The impact of COVID-19 in total hip arthroplasty: a comparison study in a center without elective surgery protocols.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic has affected elective surgeries, including Total Hip Arthroplasty (THA). This study compared THA outcomes before and after the COVID-19 outbreak in a center without a specific COVID-19 protocol for elective surgeries.
methodsThis cross-sectional study included a total of 304 THA surgeries. The study period was divided into pre-COVID-19 outbreak (April 21, 2017 to April 21, 2019) and post-COVID-19 outbreak (April 21, 2020 to April 21, 2022) groups. Demographic characteristics, etiology of operations, anesthesia time, pre-operation length of stay (LOS), post-operation LOS, comorbidities, mortality, complications, and transfusion needs were compared between the two periods.
resultsPatients during the COVID-19 pandemic were significantly younger (mean = 49.2 ± 16.3 vs. 53.7 ± 17.1 years) (P-value = 0.02). The most common indication for THA in both periods was trauma, but there was a significant difference in the distribution of etiologies between the two periods (P-value = 0.01). Pre-operative LOS was significantly longer during the COVID-19 pandemic (mean = 2.75 ± 1.69 days) compared to the pre-pandemic period (mean = 2.28 ± 1.5 days) (P-value = 0.01). However, there was no significant difference in post-operative LOS or total LOS. There were no significant differences in comorbidities between the two periods. In-hospital mortality was low in both periods, with no significant difference. Complications and transfusion needs did not show any significant differences.
conclusionsCOVID-19 pandemic led to younger THA patients, changes in etiologies, longer pre-operative LOS, but no difference in mortality, complications, anesthesia time or transfusion needs. Further research is needed to better understand the impact of the pandemic on elective orthopedic surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.